United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30’s [30x1’s sachets -

European Union - English - EMA (European Medicines Agency)

intervet international b.v - fluralaner - ectoparasiticides for systemic use, isoxazolines - dogs; cats - dogs:- for the treatment of tick and flea infestations;the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).- for the treatment of demodicosis caused by demodex canis;- for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.- for reduction of the risk of infection with babesia canis canis via transmission by dermacentor reticulatus. [chewable tablets only]cats:- for the treatment of tick and flea infestations;the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).- for the treatment of infestations with ear mites (otodectes cynotis).

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - sarolaner - ectoparasiticides for systemic use - dogs - for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of sarcoptic mange (sarcoptes scabiei).for the treatment of ear mite infestations (otodectes cynotis).for the treatment of demodicosis (demodex canis).fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - sarolaner - ectoparasiticides for systemic use - dogs - for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus,ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks. for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). for the treatment of sarcoptic mange (sarcoptes scabiei). for the treatment of ear mite infestations (otodectes cynotis). for the treatment of demodicosis (demodex canis). fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.,

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - isoxazolines, ectoparasiticides for systemic use - dogs - treatment of flea infestation in dogs (ctenocephalides felis and c. canis)  for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - ectoparasiticides for systemic use - dogs - treatment of flea (ctenocephalides felis and c. canis) infestations. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). treatment of tick (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) infestations. treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).,

Israel - English - Ministry of Health

zoetis israel holding b.v., israel - sarolaner - chewable tablets - sarolaner 5 mg - simparica veterinary is indicated for dogs:for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of sarcoptic mange (sarcoptes scabiei).for the treatment of ear mite infestations (otodectes cynotis)for the treatment of demodicosis (demodex canis)fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

Israel - English - Ministry of Health

beit-erez havat milatin ltd - afoxolaner - chewable tablets - afoxolaner 11.3 mg - treatment of flea infestation in dogs (ctenocephalides felis and c. canis) for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substancetreatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

Israel - English - Ministry of Health

beit-erez havat milatin ltd - afoxolaner - chewable tablets - afoxolaner 136 mg - treatment of flea infestation in dogs (ctenocephalides felis and c. canis) for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).